Interazioni tra farmaci
Elvitegravir / cobicistat / emtricitabine / tenofovir df + Liposomal doxorubicin
Gravità: Maggiore
Elvitegravir / cobicistat / emtricitabine / tenofovir df and Liposomal doxorubicin: major interaction.
Ultimo aggiornamento
Per operatori sanitari — solo a scopo di riferimento. Questa pagina è una sintesi breve, non è un parere medico e non sostituisce il RCP ufficiale né il giudizio clinico. Verificare sempre prima di prescrivere o dispensare.
Il contenuto clinico di questa pagina è disponibile solo in inglese.
Sintesi
Cobicistat inhibits CYP3A4, CYP2D6 and P-glycoprotein, and may increase exposure to doxorubicin released from the liposome. This could worsen myelosuppression, mucositis, hand-foot syndrome and cardiotoxicity.
Cosa significa questa interazione in parole semplici
Elvitegravir / cobicistat / emtricitabine / tenofovir df and Liposomal doxorubicin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Perché avviene
Cobicistat inhibits CYP3A4, CYP2D6 and P-glycoprotein, reducing clearance of doxorubicin.
Cosa fare
Prefer an unboosted antiretroviral regimen during therapy. If combined, monitor blood counts, mucocutaneous toxicity and cardiac function, and reduce the doxorubicin dose if toxicity appears.
Cosa chiedere al farmacista
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Per gli utenti Pro+
Sblocca la pagina completa
Crei un account e avvii una prova di Pro+ per sbloccare le indicazioni complete sulla gestione di Elvitegravir / cobicistat / emtricitabine / tenofovir df e Liposomal doxorubicin, le note aggiuntive, il dettaglio delle evidenze e il controllo delle interazioni per un'intera prescrizione.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Provi Pro+ gratis per 14 giorni sul web. Nessuna carta.
Altre interazioni di Liposomal doxorubicin
- Dengue vaccine + Liposomal doxorubicin Controindicata
- Belatacept + Liposomal doxorubicin Maggiore
- Cyclosporine + Liposomal doxorubicin Maggiore
- Dronedarone + Liposomal doxorubicin Maggiore
- Fingolimod + Liposomal doxorubicin Maggiore
- Ganciclovir + Liposomal doxorubicin Maggiore
Domande frequenti
Can I take Elvitegravir / cobicistat / emtricitabine / tenofovir df with Liposomal doxorubicin?
MediHelp rates the interaction as major. Elvitegravir / cobicistat / emtricitabine / tenofovir df and Liposomal doxorubicin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Cobicistat inhibits CYP3A4, CYP2D6 and P-glycoprotein, and may increase exposure to doxorubicin released from the liposome. This could worsen myelosuppression, mucositis, hand-foot syndrome and cardiotoxicity.
How serious is the interaction between Elvitegravir / cobicistat / emtricitabine / tenofovir df and Liposomal doxorubicin?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Prefer an unboosted antiretroviral regimen during therapy. If combined, monitor blood counts, mucocutaneous toxicity and cardiac function, and reduce the doxorubicin dose if toxicity appears.
What other medicines interact with Liposomal doxorubicin?
MediHelp also lists interactions of Liposomal doxorubicin with, for example, Dengue vaccine, Belatacept, Cyclosporine. The full list is on the Liposomal doxorubicin page.
Monografie complete, posologie e verifica delle interazioni nell'app MediHelp
Apra il riferimento completo, verifichi le interazioni tra più farmaci e usi gli strumenti di posologia nell'app MediHelp.
